CLINICAL EVALUATION OF ARRY-614, A DUAL P38/TIE2 INHIBITOR FOR PATIENTS WITH MYELODYSPLASTIC SYNDROMES, IDENTIFIES UNIQUE DISEASE-RELATED AND DRUG-RELATED BIOMARKERS G. Garcia-Manero,R. Komrokji, S. Winski, J. Garrus, L. Cable, D. Kilz, D. Chantry, G. Hogeland,S. Bell,S. Rush,M. Ptaszynski,A. List,H. KhouryHAEMATOLOGICA（2012）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
